Microbot Medical Inc. filed its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2026, announcing significant operational growth. Revenue increased by more than 100% compared to the first quarter of 2026, driven by repeat orders and expanded utilization following the Full Market Release in April. The company added new health systems in Massachusetts, North Carolina, Michigan, and Pennsylvania, expanding its sales footprint from four to eight territories. It also entered agreements with Lovell Government Services Inc. for federal healthcare access and Sanmina for a second manufacturing site. Additionally, Israel granted marketing clearance for the LIBERTY System, marking the first regulatory approval outside the U.S. Microbot Medical Inc. is a commercial-stage medical device company focused on transforming endovascular procedures through advanced robotic technology.

Microbot Medical Inc. entered into Addendum #4 to the employment agreement with Chief Financial Officer Rachel Vaknin on August 6, 2026. The addendum increases Ms. Vaknin's annual base salary to NIS 864,000, equivalent to $288,000 at a presumed exchange rate of 3:1, effective as of August 1, 2026. This company operates in the medical device industry and develops minimally invasive surgical technologies.

Microbot Medical Inc. reported greater than 100% growth in revenue and new customers for the second quarter ended June 30, 2026, compared to the first quarter ended March 31, 2026. Microbot Medical Inc. is a medical technology company that develops micro-robotic systems for minimally invasive surgery.

Microbot Medical Inc. has entered into a Letter of Agreement with Sanmina Corporation to manufacture the LIBERTY Endovascular Robotic System. This agreement is intended to expand manufacturing capacity to meet expected demand and support the company's cost reduction strategy. Microbot Medical Inc. is a medical technology company that develops endovascular robotic systems.

Microbot Medical Inc. announced via press release that it has won the Innovative Start-Up Award from Surgical Robotics Technology. Microbot Medical Inc. is a medical technology company that develops surgical robotics.**